Thanks for postingILUVBEER99 said:serious question, who is bullying you? It's a stock, some go up, some go down.
Sell it now at 3.12.I bought 7500 back at 2.90 like an idiot.
Thats sort of where I'm at, except for #2 its about getting in on the spike down after no EUA.I was tempted to buy more at 2.80. I chose not to because I am already more invested than I ever intended to be. I could have dropped my cost basis down by about a quarter per share, which might have been worth it short term, but two things stopped me.
1. If it goes up from there, it would be on great news and it is going way above my cost basis, and i am going to be happy having what I have when it does that.
2. If it goes down, that sucks.
Good point. I also did think about that. If this news doesn't come this week, or if it comes anything other than EUA, I can buy lower if I choose to. If not, I am satisfied with where I'm at if it does go back up.Thats sort of where I'm at, except for #2 its about getting in on the spike down after no EUA.
Haven't checked in on this thread since I sold my CYDY a month or so ago. Just skipped right to the last page to see what was going on and this was one of the first things I see. Reminds me of what was being said about CYDY every single week all through the spring.Chaz McNulty said:There should be news this week.
If I’m counting on CYDY to pay for the wedding, someone fire up the pizza order.Not give my daughter a wildly unnecessary $100k wedding rich.
How many years until the first one?If I’m counting on CYDY to pay for the wedding, someone fire up the pizza order.
We’ve got time. By then, with a daily -7%, I’m not sure we’ll have enough pizza for everyone. BYO?How many years until the first one?
Nothing but good news ever about the actual drug. Frustrating.American Association for Cancer Research
August 2020 Publication
Abstract CT233: Phase Ib/II study of leronlimab (PRO 140) combined with carboplatin in CCR5+ mTNBC patients
Conclusions: Leronlimab (PRO 140), a CCR5 antagonist mAb, in combination with carboplatin is currently enrolling newly diagnosed mTNBC. The preliminary analysis shows safety and tolerability of the combination and continue to enroll patients with initial promising clinical activity, potentially suggesting the future availability of a new effective agent in the management of this serious condition.
Price should drop 15% tomorrow on this news.Nothing but good news ever about the actual drug. Frustrating.
At this point I’d take 5 bucks a shareOK I am capitulating. I will accept a buyout at $20/share now.
Written in April but just published I believe.So that's a summary of something from April written by the same people who always do everything like NP, Bruce, and Jay.
Distribution agreement to get the product where it needs to go. Valid for United States and its territories, from what I can see.what means this? Form 8-k filed
http://archive.fast-edgar.com/20200818/AN22822EZM2RTTZ2222M2ZYNBFKGEZ22X222/
Some guy stepping down from board, and they had to re-file a 10k because...gasp...they left something out.what means this? Form 8-k filed
http://archive.fast-edgar.com/20200818/AN22822EZM2RTTZ2222M2ZYNBFKGEZ22X222/
Yeah, finally saw that on my second quick viewing. Whole lot of nothingSome guy stepping down from board, and they had to re-file a 10k because...gasp...they left something out.
Yep. Missed that the first time through.Some guy stepping down from board, and they had to re-file a 10k because...gasp...they left something out.
.... which will find its way into a hit piece tomorrow that results in ... wait for it ... a 7% decline in the stock value!Yeah, finally saw that on my second quick viewing. Whole lot of nothing
Gonna have to let it have a green day soon. Gotta keep the hope alive so people keep buying the "bottom".... which will find its way into a hit piece tomorrow that results in ... wait for it ... a 7% decline in the stock value!
Are you guys still looking for this? because I might have found it.It went from .30 to $10.00So much of this has been covered before but here are a few quickly.
stock promo using YouTube and paid websites
questionable backers
insider selling
unable to get favorable financing
no independent studies published
promises / timelines not kept
thats the pump. Where’s the dump?
He ain’t wrong.Are you guys still looking for this? because I might have found it.
I’m sorry I wasn’t able to convince most of you on the risks on this one. 100% serious.
You know if I would have listened to your brilliance when you offered it unsolicited to me, you would have cost me 200k at today's cydy price. Don't pat yourself on the back too hard there Skippy.Are you guys still looking for this? because I might have found it.
I’m sorry I wasn’t able to convince most of you on the risks on this one. 100% serious.
Wait didn’t you buy Hgen at like 6 bucks? You’re not exactly warren buffet either.Are you guys still looking for this? because I might have found it.
I’m sorry I wasn’t able to convince most of you on the risks on this one. 100% serious.
No shorting tomorrow so should be green.Gonna have to let it have a green day soon. Gotta keep the hope alive so people keep buying the "bottom"